Chronic Exposure to Fluoride Affects GSH Level and NOX4 Expression in Rat Model of This Element of Neurotoxicity.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
09 03 2020
Historique:
received: 10 01 2020
revised: 25 02 2020
accepted: 26 02 2020
entrez: 19 3 2020
pubmed: 19 3 2020
medline: 19 3 2021
Statut: epublish

Résumé

Exposure of neural cells to harmful and toxic factors promotes oxidative stress, resulting in disorders of metabolism, cell differentiation, and maturation. The study examined the brains of rats pre- and postnatally exposed to sodium fluoride (NaF 50 mg/L) and activity of NADPH oxidase 4 (NOX4), catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione reductase (GR), concentration of glutathione (GSH), and total antioxidant capacity (TAC) in the cerebellum, prefrontal cortex, hippocampus, and striatum were measured. Additionally, NOX4 expression was determined by qRT-PCR. Rats exposed to fluorides (F-) showed an increase in NOX4 activity in the cerebellum and hippocampus, a decrease in its activity in the prefrontal cortex and hippocampus, and upregulation of NOX4 expression in hippocampus and its downregulation in other brain structures. Analysis also showed significant changes in the activity of all antioxidant enzymes and a decrease in TAC in brain structures. NOX4 induction and decreased antioxidant activity in central nervous system (CNS) cells may be central mechanisms of fluoride neurotoxicity. NOX4 contributes to blood-brain barrier damage, microglial activation, and neuronal loss, leading to impairment of brain function. Fluoride-induced oxidative stress involves increased reactive oxygen speciaes (ROS) production, which in turn increases the expression of genes encoding pro-inflammatory cytokines.

Identifiants

pubmed: 32182821
pii: biom10030422
doi: 10.3390/biom10030422
pmc: PMC7175316
pii:
doi:

Substances chimiques

Reactive Oxygen Species 0
Sodium Fluoride 8ZYQ1474W7
NADPH Oxidase 4 EC 1.6.3.-
Nox4 protein, rat EC 1.6.3.-
Glutathione GAN16C9B8O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare they have no actual or potential competing financial interests.

Références

Toxicology. 2007 Jul 17;236(3):208-16
pubmed: 17537562
Toxicology. 2003 Feb 1;183(1-3):235-42
pubmed: 12504354
Clin Calcium. 2007 Feb;17(2):217-23
pubmed: 17272879
J Neuroinflammation. 2011 Oct 05;8:129
pubmed: 21975039
Curr Alzheimer Res. 2004 May;1(2):111-9
pubmed: 15975075
Mediators Inflamm. 2012;2012:401264
pubmed: 22544998
Genes Cells. 2005 Dec;10(12):1139-51
pubmed: 16324151
Clin Sci (Lond). 2011 Feb;120(4):131-41
pubmed: 21039341
Biol Trace Elem Res. 2017 Jun;177(2):224-234
pubmed: 27787813
Cell Signal. 2006 Jan;18(1):69-82
pubmed: 15927447
Biol Trace Elem Res. 2011 Dec;144(1-3):1083-94
pubmed: 21755305
Biomed Pharmacother. 2015 Aug;74:101-10
pubmed: 26349970
Toxicol Lett. 2008 Jun 10;179(1):1-5
pubmed: 18485627
Neurochem Res. 2010 Jul;35(7):1017-28
pubmed: 20336367
Mol Neurodegener. 2017 Jan 17;12(1):7
pubmed: 28095923
J Cell Biol. 2008 Jun 30;181(7):1129-39
pubmed: 18573911
Neurotoxicol Teratol. 1998 Sep-Oct;20(5):537-42
pubmed: 9761592
Dev Neurosci. 2013;35(4):293-305
pubmed: 23751520
Trends Pharmacol Sci. 2012 Jun;33(6):295-303
pubmed: 22503440
Chem Biol Interact. 2017 Jan 5;261:1-10
pubmed: 27840156
Nat Med. 2004 Jul;10 Suppl:S18-25
pubmed: 15298006
Curr Neuropharmacol. 2011 Dec;9(4):662-73
pubmed: 22654724
Exp Neurobiol. 2015 Dec;24(4):325-40
pubmed: 26713080
Environ Toxicol Pharmacol. 2014 Sep;38(2):684-99
pubmed: 25233527
Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):1971-3
pubmed: 17034342
Neurotoxicology. 2019 Sep;74:81-90
pubmed: 31175943
Circ Res. 2005 Apr 29;96(8):818-22
pubmed: 15860762
Toxicol Lett. 2013 Nov 25;223(2):236-51
pubmed: 24050947
Antioxid Redox Signal. 2014 Jun 10;20(17):2815-37
pubmed: 24206089
Biol Trace Elem Res. 2016 Nov;174(1):150-157
pubmed: 27052310
Mol Neurodegener. 2017 Nov 13;12(1):84
pubmed: 29132391
Chemosphere. 2018 Nov;211:112-119
pubmed: 30071422
Biomed Pharmacother. 2004 Jan;58(1):39-46
pubmed: 14739060
Toxicol Mech Methods. 2014 Jan;24(1):31-6
pubmed: 24024668
Chemosphere. 2015 Nov;139:422-7
pubmed: 26232646
Free Radic Biol Med. 2013 Sep;62:170-185
pubmed: 23000246
J Trace Elem Med Biol. 2016 Jan;33:54-67
pubmed: 26653744
Zhonghua Bing Li Xue Za Zhi. 1992 Aug;21(4):218-20
pubmed: 1473206
Environ Health Perspect. 2012 Oct;120(10):1362-8
pubmed: 22820538
Int J Dev Neurosci. 2015 Dec;47(Pt B):298-303
pubmed: 26390955
Biol Trace Elem Res. 2011 Feb;139(2):197-203
pubmed: 20217272
J Biol Chem. 2001 Jan 12;276(2):1417-23
pubmed: 11032835
Environ Sci Technol. 2011 Feb 1;45(3):1121-6
pubmed: 21166449
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):12315-12320
pubmed: 29087944
Zhonghua Bing Li Xue Za Zhi. 1986 Dec;15(4):297-9
pubmed: 2955919
Cad Saude Publica. 2007;23 Suppl 4:S579-87
pubmed: 18038039
Nutrition. 2002 Oct;18(10):872-9
pubmed: 12361782
J Hematol Oncol. 2013 Feb 25;6:19
pubmed: 23442817
Neurobiol Dis. 2015 Dec;84:4-21
pubmed: 26024962
J Neurosci. 2000 Jan 1;20(1):RC53
pubmed: 10627630
Med Sci Monit. 2006 Jan;12(1):BR8-14
pubmed: 16369462
J Biol Chem. 2011 Dec 30;286(52):44557-68
pubmed: 22072713
Cell Mol Immunol. 2015 Jan;12(1):5-23
pubmed: 25263488
Pathophysiology. 2015 Mar;22(1):39-48
pubmed: 25577494

Auteurs

Karolina Dec (K)

Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, Broniewskiego 24 Str., 70-460 Szczecin, Poland.

Agnieszka Łukomska (A)

Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, Broniewskiego 24 Str., 70-460 Szczecin, Poland.
Laboratory of Neuroplasticity, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093 Warsaw, Poland.

Karolina Skonieczna-Żydecka (K)

Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, Broniewskiego 24 Str., 70-460 Szczecin, Poland.

Karolina Jakubczyk (K)

Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, Broniewskiego 24 Str., 70-460 Szczecin, Poland.

Maciej Tarnowski (M)

Department Physiology, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72 av., 70-111 Szczecin, Poland.

Anna Lubkowska (A)

Department of Functional Diagnostics and Physical Medicine, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, Żołnierska 54, 71-210 Szczecin, Poland.

Irena Baranowska-Bosiacka (I)

Department of Biochemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72 av., 70-111 Szczecin, Poland.

Daniel Styburski (D)

Department of Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72 av., 70-111 Szczecin, Poland.

Marta Skórka-Majewicz (M)

Department of Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72 av., 70-111 Szczecin, Poland.

Dominika Maciejewska (D)

Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, Broniewskiego 24 Str., 70-460 Szczecin, Poland.

Izabela Gutowska (I)

Department of Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72 av., 70-111 Szczecin, Poland.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH